Oxular Limited
09331313
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/10/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 19/11/2025
Due 03/12/2026
Industry
Officers
director · Since 20/12/2024
SENIOR VICE PRESIDENT
AMERICAN · UNITED STATES · Age 48
Also on 2 other boards
director · Since 20/12/2024
SENIOR VICE PRESIDENT
AMERICAN · UNITED STATES · Age 53
Also on 2 other boards
Persons with Significant Control
Regeneron Pharmaceuticals, Inc.
777, Old Saw Mill River Road, Tarrytown, 10591
Reg: 1226128 · New York State Department Of State'S Division Of Corporations · New York Corporation
Notified 20/12/2024
Charges0 outstanding
HSBC UK BANK PLC
SILICON VALLEY BANK
CompanyRankvs 580+ SIC 72110 peers61
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
in accordance with IFRS as adopted by the UK , subject to any material departures disclosed and explained in the financial statements; ∙ assess the Group and Company 's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and ∙ use the going concern basis of accounting unless they either intend to liquidate the Group or the Company or to cease
Key FinancialsYear ending 31/10/2023
Net Worth
£230k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
£11.8M
Current Liabilities
£3.9M
Profit After Tax
-£11.8M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 3.05 | -£16.5M |
| 2021 | 12.60 | +£15.5M |
| 2020 | 9.96 | — |
Derived from filed accounts. Not audited figures.